Natural compounds and strategies for fighting against drug resistance in cancer: a special focus on phenolic compounds and microRNAs
American Journal of Physiology-Cell Physiology · 2025
DOI: 10.1152/ajpcell.00428.2024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Nina Petrović und 2 weiteren Autor:innen. Beteiligte Einrichtung: "VINČA" Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia. Hauptthemen laut MEDLINE: MicroRNAs, Drug Resistance, Neoplasm, Neoplasms, Phenols. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 165 Literaturangaben. Gefördert von: Ministry of Science, Technological Development and Innovation of the Republic of Serbia.
Abstract (Originalsprache)
Bioactive phytochemicals, phenolic compounds, terpenoids, and alkaloids, exert antioxidative, anti-inflammatory, antigenotoxic, and anticancer effects, simultaneously showing minimal or no toxicity on normal, healthy cells. Phytochemicals targeting various signaling pathways and multiple mechanisms underlying intrinsic and acquired multidrug resistance (MDR) in cancer cells make them invaluable tools for the development of novel strategies for fighting against anticancer drug resistance in different types of cancer, which is one of the ultimate goals of modern oncology research. As MDR is described to be a simultaneous development of resistance to multiple drugs with different chemical structures, mechanisms of action, and targets it is not surprising that multiple factors, such as genetic and epigenetic changes, as well as noncoding RNAs, including microRNAs may significantly contribute to the development MDR in cancer cells, and its targeting and modulation of their expression to sensitize cells to treatment. This review implies that some natural compounds, such as curcumin, resveratrol, kaempferol, allicin, and quercetin, have the potential to interact with highly oncogenic and/or proinflammatory miRNAs, such as miR-21/155/663/146a, significantly influencing the response to cancer therapy. This article aims to point out how natural compounds may be used, accompanied by miRNAs mimics or miRNA inhibitors to treat specific types of cancer and its subtypes to overcome multidrug resistance. The main challenge is to determine the proper doses and concentrations of both miRNAs and compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- "VINČA" Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia.
- Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.
ORCID-Profile: Ivana Z Matić, Tatjana Stanojković
Förderung
- Ministry of Science, Technological Development and Innovation of the Republic of Serbia
Zitieren
APA
Petrović, N., Matić, I. Z., & Stanojković, T. (2025). Natural compounds and strategies for fighting against drug resistance in cancer: a special focus on phenolic compounds and microRNAs. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00428.2024
Vancouver
Petrović N, Matić IZ, Stanojković T. Natural compounds and strategies for fighting against drug resistance in cancer: a special focus on phenolic compounds and microRNAs. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00428.2024
BibTeX
@article{Petrovi2025,
author = {Petrović, Nina and Matić, Ivana Z and Stanojković, Tatjana},
title = {Natural compounds and strategies for fighting against drug resistance in cancer: a special focus on phenolic compounds and microRNAs},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
doi = {10.1152/ajpcell.00428.2024}
}
EUVIMED